
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
Description
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
Stay Ahead of the Curve with Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029: With the global demand for infectious disease IVD products projected to surge, understanding market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern.
As infectious diseases continue to pose significant global health challenges, diagnostic testing has emerged as a vital tool in detecting and managing these threats. Today, infectious disease testing stands at the forefront of the rapidly expanding in vitro diagnostics (IVD) industry, representing one of its largest and most dynamic segments.
This comprehensive market research report from Kalorama Information delves into the world of infectious disease IVD, presenting unparalleled insights and forecasts for 2024-2029. Designed for industry professionals, investors, and market strategists, this report will equip you with the knowledge needed to stay ahead in a competitive and rapidly evolving sector.
Report Features:
- Comprehensive Market Coverage: Understand the dynamic landscape of infectious disease diagnostics, spanning key test categories such as:
- Healthcare-Associated Infections (HAIs)
- COVID-19
- Hepatitis
- STIs
- Influenza
- HIV/AIDS
- Tuberculosis
- TORCH
- Other infectious diseases (including Dengue Fever, Emerging Infections, Fungal, Lyme Disease, Malaria, Other Parasitic, RSV, Streptococcal)
- Global Reach with Local Insights: Gain valuable perspectives on opportunities in diverse geographic regions, including North America, Western Europe, Asia/Pacific, and emerging markets across Central & South America, Africa, and the Middle East.
- Strategic Market Drivers: Explore the macroeconomic and healthcare trends driving the need for advanced diagnostics and how aging populations and globalized threats are influencing market growth.
- Competitive Intelligence: Analyze the leading players and their IVD innovations, helping you benchmark against industry leaders and identify potential partnerships or competitive advantages.
Table of Contents
281 Pages
- A Mix of Traditional and Emerging Testing Technologies
- Market Drivers
- The World Infectious Disease Testing Market
- Major Findings of the Report
- Scope and Methodology
- Overview
- Population
- Age Distribution
- Macroeconomic Environment
- Global Healthcare Trends
- Overview
- Healthcare-Associated Infections (HAIs)
- COVID-19
- Hepatitis IVD Products
- Sexually Transmitted Infections (STIs)
- Influenza
- HIV/AIDS IVD Products
- Tuberculosis (TB)
- TORCH
- All Other Infectious Disease IVD Products
- Global Infectious Disease IVD Technologies
- Global Infectious Disease IVD Demand by Market
- Overview
- North America
- Western Europe
- Asia/Pacific
- Other Regions
- Abbott Laboratories
- Becton Dickinson and Company
- Bio-Rad Laboratories
- bioMérieux
- Bruker Corporation
- Danaher Corporation
- DiaSorin
- Grifols S.A.
- Hologic
- QIAGEN
- QuidelOrtho Corporation
- Roche Holding
- Siemens Healthineers
- Thermo Fisher Scientific
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.